These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37708829)

  • 41. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
    Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
    Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous Expression of Chicken Granulocyte Monocyte Colony-Stimulating Factor and the Hemagglutinin-Neuraminidase Epitope of the Virulent Newcastle Disease Virus Genotype VII C22 Strain in a Functional Synthetic Recombinant Adenovirus as a Genotype-Matched Vaccine with Potential Antiviral Activity.
    Adam FEA; Zhao X; Guan Z; Chang Z; Thrusfield M; Lu K; El Tigani-Asil ETA; Terab AMA; Ismael M; Tong L; Prince-Theodore DW; Luo C; Xiao S; Wang X; Liu H; Yang Z
    Microbiol Spectr; 2023 Jun; 11(3):e0402422. PubMed ID: 37036344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different kinetics of chicken interferon-alpha signalling transduction responses following immunization of broiler chickens with different Newcastle disease virus vaccines and infection with virulent genotype VIId strain.
    Hassanin O; Abdallah F; Ali HA; AlGabr N; Mohamed MHA
    Avian Pathol; 2021 Feb; 50(1):85-97. PubMed ID: 33146541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated Challenge with Virulent Newcastle Disease Virus Does Not Decrease the Efficacy of Vaccines.
    Taylor TL; Miller PJ; Olivier TL; Montiel E; Cardenas Garcia S; Dimitrov KM; Williams-Coplin D; Afonso CL
    Avian Dis; 2017 Jun; 61(2):245-249. PubMed ID: 28665733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
    Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R
    Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host response to successive challenges with lentogenic and velogenic Newcastle disease virus in local chickens of Ghana.
    Botchway PK; Amuzu-Aweh EN; Naazie A; Aning GK; Otsyina HR; Saelao P; Wang Y; Zhou H; Walugembe M; Dekkers J; Lamont SJ; Gallardo RA; Kelly TR; Bunn D; Kayang BB
    Poult Sci; 2022 Nov; 101(11):102138. PubMed ID: 36126448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-evaluation the immune efficacy of Newcastle disease virus vaccine in commercial laying chickens.
    Han Q; Gao X; Wu P; Xiao S; Wang X; Liu P; Tong L; Hao H; Zhang S; Dang R; Yang Z
    Res Vet Sci; 2017 Apr; 111():63-66. PubMed ID: 28043009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
    Vagnozzi A; García M; Riblet SM; Zavala G
    Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
    Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
    Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
    Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.